What kind of challenge would you like to see in a future of compound: 149554-29-0

If you want to learn more about this compound(6-(Piperazin-1-yl)nicotinonitrile)Computed Properties of C10H12N4, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(149554-29-0).

Computed Properties of C10H12N4. The mechanism of aromatic electrophilic substitution of aromatic heterocycles is consistent with that of benzene. Compound: 6-(Piperazin-1-yl)nicotinonitrile, is researched, Molecular C10H12N4, CAS is 149554-29-0, about Synthesis of new and potent analogs of anti-tuberculosis agent 5-nitrofuran-2-carboxylic acid 4-(4-benzylpiperazin-1-yl)benzylamide with improved bioavailability. Author is Tangallapally, Rajendra P.; Lee, Robin E. B.; Lenaerts, Anne J. M.; Lee, Richard E..

Previously, the lead compound 5-nitrofuran-2-carboxylic acid 4-(4-benzylpiperazin-1-yl)benzylamide was identified in our anti-tuberculosis drug discovery program. Although this compound demonstrated excellent in vitro activity, it did not meet the expected in vivo profiles due to structural features that resulted in rapid metabolic cleavage and poor absorption, which therefore limited its bioavailability. In efforts to increase the bioavailability, a new series of analogs was successfully synthesized using three modification schemes: replacement of the benzyl group on the piperazine C-ring with carbamate and urea functional groups; introduction of a nitrogen atom into the aromatic ring-B; and expansion of the ring-B to a bicyclic tetrahydroisoquinoline moiety. These modifications retained strong activity and in some case gained superior anti-tuberculosis activity, increased absorption, and serum half life.

If you want to learn more about this compound(6-(Piperazin-1-yl)nicotinonitrile)Computed Properties of C10H12N4, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(149554-29-0).

Reference:
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI